Anúncio
Anúncio
CLDX
Celldex Therapeutics, Inc
27.36
USDPatrocinado
+0.01
+0.03%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
27.36
0.00
-0.01%
Relatórios de Lucros CLDX
Rácio de surpresa positiva
CLDX separação 28 de 39 últimas estimativas.
72%
Próximo Relatório
Data do Próximo Relatório
25 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.62M
/-$1.01
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+37.70%
/+42.25%
Celldex Therapeutics, Inc earnings per share and revenue
On 10 de nov. de 2025, CLDX reported earnings of -1.01 USD per share (EPS) for Q3 25, missing the estimate of -0.91 USD, resulting in a -9.94% surprise. Revenue reached --, compared to an expected 1.01 milhão, with a -100.00% difference. The market reacted with a +7.50% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -1.01 USD, with revenue projected to reach 1.62 milhão USD, implying an aumentar of 0.00% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Celldex Therapeutics, Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Celldex Therapeutics, Inc reported EPS of -$1.01, missing estimates by -9.94%, and revenue of $0.00, -100% below expectations.
How did the market react to Celldex Therapeutics, Inc's Q3 2025 earnings?
The stock price moved up 7.5%, changed from $22.67 before the earnings release to $24.37 the day after.
When is Celldex Therapeutics, Inc expected to report next?
The next earning report is scheduled for 25 de fev. de 2026.
What are the forecasts for Celldex Therapeutics, Inc's next earnings report?
Based on 17
analistas, Celldex Therapeutics, Inc is expected to report EPS of -$1.01 and revenue of $1.62M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio